Pfizer 1Q revenue misses analyst estimates as sales of Ibrance, Xeljanz disappoint

Daniel Fowler
May 9, 2018

It has outperformed by 1.89% the S&P500. Maryland-based Df Dent Co has invested 0.04% in Pfizer Inc. Kempner Capital Management Inc bought 44,827 shares as the company's stock declined 4.63% with the market. The institutional investor held 73,192 shares of the health care company at the end of 2017Q4, valued at $2.65M, down from 81,709 at the end of the previous reported quarter. Roosevelt Investment Group Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $210.58 billion market cap company. About 4.43M shares traded.

Pfizer Inc. (PFE - Free Report) is one of the most well-known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products. PFE underperformed by 9.12% the S&P500. (NYSE:PFE) for 195,801 shares. The stock has "Hold" rating by Berenberg on Thursday, May 12. Therefore 25% are positive. DaVita had 40 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Barclays Capital to "Equal-Weight" on Thursday, April 5. BMO Capital Markets set a $39.00 price target on shares of Pfizer and gave the company a "buy" rating in a report on Monday, January 8th. The company was maintained on Tuesday, April 24 by Jefferies. Scotia Capital maintained Marathon Petroleum Corporation (NYSE:MPC) on Wednesday, January 10 with "Hold" rating. Intrust Bank NA now owns 65,268 shares of the biopharmaceutical company's stock valued at $2,192,000 after buying an additional 1,596 shares during the period.

He said the company has 15 potential blockbuster medicines in the pipeline that could be launched by 2022.

Investors sentiment increased to 0.96 in 2017 Q4. That's change of 0.10, from 2017Q3's 0.96.

A number of institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its stake in shares of Pfizer by 4.8% during the second quarter. Btr Cap reported 252,988 shares. White Pine Ltd Liability Co holds 0.17% in Pfizer Inc. Nippon Life accumulated 1.03 million shares. Utah Retirement Sys stated it has 90,122 shares or 0.12% of all its holdings. Old Bancorporation In holds 0.51% in Pfizer Inc. Wealth Enhancement Advisory Service Limited Liability Company owns 0.15% invested in Pfizer Inc. Strategic Financial Inc, New York-based fund reported 133,382 shares. (NYSE:PFE). Davenport & Ltd Liability holds 255,613 shares or 0.11% of its portfolio. (NYSE:PFE). Lagoda Investment Limited Partnership reported 0.02% in Pfizer Inc. Insiders own 0.06% of the company's stock. Riverpoint Cap Mgmt has 172,628 shares. Clarivest Asset Mngmt Ltd Llc reported 2,987 shares or 0% of all its holdings. (NYSE:SB) to report earnings on May, 17. Hall Laurie J Trustee invested 0.78% of its portfolio in Pfizer Inc. The shares were sold at an average price of $36.59, for a total value of $2,550,286.41. Fjarde Ap accumulated 159,568 shares or 0.16% of the stock.

Microsoft Patches Two Zero-Day Flaws this Month
This had allowed people to force Internet Explorer to load, no matter what browser someone was already using. The bug, designated as CVE-2018-8120, is being exploited in the wild.

PFE registered $12.99 million net activity with 0 buys and 12 selling transactions since December 15, 2017. (NYSE:PFE). Canal Ins Communications holds 2.14% or 166,050 shares in its portfolio. The insider HILL CHARLES H sold 26,779 shares worth $986,292.

Loews Corp decreased its stake in Pfizer Inc (PFE) by 3.45% based on its latest 2017Q4 regulatory filing with the SEC. Following the completion of the transaction, the director now directly owns 1,000 shares in the company, valued at $36,790. (NYSE:PFE) rating on Thursday, July 14.

Pfizer said that Ibrance had raked in sales of $933m in the first quarter, up 37.4% from a year earlier but missing analysts' estimates of $956.6 million, according to Thomson Reuters. (NYSE:PFE) shares were sold by CORNWELL W DON. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and eight have given a buy rating to the company.

Merck has narrowed and raised its full-year 2018 revenue range to be between $41.8 billion and $43.0 billion, including an approximately 2 percent positive impact from foreign exchange at current exchange rates. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Societe Generale on Wednesday, April 6 with "Hold". The rating was maintained by Jefferies with "Buy" on Tuesday, June 14. The stock of Pfizer Inc. (NYSE:PFE) rating on Sunday, January 28. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) earned "Buy" rating by Jefferies on Thursday, August 4. The firm earned "Hold" rating on Monday, October 16 by SunTrust. Finally, Vetr cut Pfizer from a "buy" rating to a "hold" rating and set a $37.98 price objective on the stock.in a research report on Monday, January 15th. As a outcome of the price decrease, Snap Inc. now has a current market value of 17.72B. (NYSE:PFE) on Tuesday, March 13. The stock presently has a consensus rating of Hold and an average target price of $39.30. As per Tuesday, November 21, the company rating was maintained by BMO Capital Markets.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER